F

Firebrick Pharma Ltd
ASX:FRE

Watchlist Manager
Firebrick Pharma Ltd
ASX:FRE
Watchlist
Price: 0.063 AUD
Market Cap: 15.8m AUD

Net Margin

-897.9%
Current
Improving
by 238 455.5%
vs 3-y average of -239 353.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-897.9%
=
Net Income
AU$-2.6m
/
Revenue
AU$293.4k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-897.9%
=
Net Income
AU$-2.6m
/
Revenue
AU$293.4k

Peer Comparison

Country Company Market Cap Net
Margin
AU
Firebrick Pharma Ltd
ASX:FRE
15.8m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
No Stocks Found

Market Distribution

Lower than 73% of companies in Australia
Percentile
27th
Based on 4 004 companies
27th percentile
-897.9%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Firebrick Pharma Ltd
Glance View

Market Cap
15.8m AUD
Industry
Pharmaceuticals

Firebrick Pharma Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The firm is focused to develop Nasodine, a nasal spray that contains the broad spectrum antimicrobial agent called povidone-iodine. The firm is engaged in product formulation, packaging and manufacturing development. Nasodine nasal spray medicine targets the cause of colds, where they start in the nose. Its nasal spray is responsible for respiratory infections, such as the common cold. The firm's Series C funding, Phase III trial has been completed.

FRE Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-897.9%
=
Net Income
AU$-2.6m
/
Revenue
AU$293.4k
What is Firebrick Pharma Ltd's current Net Margin?

The current Net Margin for Firebrick Pharma Ltd is -897.9%, which is above its 3-year median of -239 353.4%.

How has Net Margin changed over time?

Over the last 3 years, Firebrick Pharma Ltd’s Net Margin has increased from -92 592.7% to -897.9%. During this period, it reached a low of -850 262.5% on Jun 30, 2023 and a high of -815.8% on Dec 31, 2024.

Back to Top